These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17872909)

  • 21. Follicular progesterone elevations with ovulation induction for IVF.
    Kasum M; Simunić V; Vrčić H; Stanić P; Orešković S; Beketić-Orešković L
    Gynecol Endocrinol; 2014 Aug; 30(8):537-41. PubMed ID: 24841851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dose and duration of continuous GnRH-agonist treatment on induction of estrus in beagle dogs: competing and concurrent up-regulation and down-regulation of LH release.
    Concannon PW; Temple M; Montanez A; Newton L
    Theriogenology; 2006 Oct; 66(6-7):1488-96. PubMed ID: 16563490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
    Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists.
    Kolibianakis EM; Papanikolaou EG; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    Hum Reprod; 2006 Apr; 21(4):1012-7. PubMed ID: 16339166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.
    De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C
    Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of lead follicle diameter to initiate gonadotropin-releasing hormone antagonist does not affect in vitro fertilization clinical pregnancy, implantation, or live birth rates: a prospective, randomized study.
    Dayal MB; Frankfurter D; O'Hern C; Peak D; Dubey A; Gindoff PR
    Fertil Steril; 2009 Dec; 92(6):2047-9. PubMed ID: 19591990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GnRH antagonists.
    Coccia ME; Comparetto C; Bracco GL; Scarselli G
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S44-56. PubMed ID: 15196716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure.
    Fisch JD; Keskintepe L; Sher G
    Fertil Steril; 2008 Feb; 89(2):342-7. PubMed ID: 17562336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early cleavage does not predict treatment outcome following the use of GnRH antagonists in women older than 35.
    Yang WJ; Hwu YM; Lee RK; Li SH; Lin SY; Fleming S
    Fertil Steril; 2007 Dec; 88(6):1573-8. PubMed ID: 17555755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
    Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
    Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of gonadotropin-releasing hormone antagonists in poor responders.
    Mahutte NG; Arici A
    Fertil Steril; 2007 Feb; 87(2):241-9. PubMed ID: 17113088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
    Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal stimulation protocols for in vitro fertilization.
    Muasher SJ; Abdallah RT; Hubayter ZR
    Fertil Steril; 2006 Aug; 86(2):267-73. PubMed ID: 16753157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GnRH agonist and GnRH antagonist in intracytoplasmic injection cycles.
    Rashid MR; Ong FB; Omar MH; Ng SP; Nurshaireen A; Sharifah-Teh NS; Fazilah AH; Zamzarina MA
    Med J Malaysia; 2008 Jun; 63(2):113-7. PubMed ID: 18942295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate.
    Orvieto R; Patrizio P
    Reprod Biomed Online; 2013 Jan; 26(1):4-8. PubMed ID: 23186555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [GnRH antagonists and embryo implantation potential].
    Giorgetti C
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S36-8. PubMed ID: 15643686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry.
    Griesinger G; Felberbaum R; Diedrich K
    Hum Reprod; 2005 Sep; 20(9):2373-5. PubMed ID: 15932915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian stimulation for in vitro fertilization in patients with endometriosis.
    Zikopoulos K; Kolibianakis EM; Devroey P
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):651-5. PubMed ID: 15225190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.